AD
Ercalcidiol(CAS: 21343-40-8)
CAS Number
Related Products
N-(2-Methoxyphenyl)acetamide
CAS Number: 93-26-5
Diphenylphosphine oxide
CAS Number: 4559-70-0
2,6-Dimethyl-2,4,6-octatriene
CAS Number: 673-84-7
![1,2-Dimethoxy-12-methyl[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium 13-methyl[1,3]benzodioxolo[5,6-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium chloride (1:1:2)](https://static.chemtradehub.com/structs/112/112025-60-2-37be.webp)
![(7aS,13aS)-9,10-Dimethoxy-3,3-dimethyl-13,13a-dihydro-3H-chromeno[3,4-b]pyrano[2,3-h]chromen-7(7aH)-one](https://static.chemtradehub.com/structs/522/522-17-8-8dd3.webp)
2,4,5,6-Tetraaminopyrimidine Sulfate
CAS Number: 5392-28-9
Other Suppliers for Ercalcidiol
Basic Information
Molecular Formula
C28H44O2
Molecular Weight
412.66 g/mol
Physical State
No data available
Physical Properties
Melting Point
45-51°C
Boiling Point
542.3°C at 760 mmHg
Density
1.02
Chemical Identifiers
SMILES
CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C
InChIKey
KJKIIUAXZGLUND-FOZBYKFWSA-N
Database References
MDL Number
MFCD02683431
FAQ
Ercalcidiol (CAS: 21343-40-8) is a vitamin D metabolite used in the treatment of hypocalcemia and secondary hyperparathyroidism in patients with chronic kidney disease. It is an active form of vitamin D and is typically administered orally.
Ercalcidiol (CAS: 21343-40-8) is primarily used in the management of hypocalcemia and secondary hyperparathyroidism in patients with chronic kidney disease. It helps to maintain normal calcium levels and reduce complications associated with vitamin D deficiency.
Ercalcidiol (CAS: 21343-40-8) is generally considered safe when used as directed. However, it is important to follow medical advice and adhere to prescribed dosages to avoid potential side effects such as hypercalcemia, which can cause various health issues.
Ercalcidiol (CAS: 21343-40-8) should be stored in a cool, dry place away from direct sunlight and moisture. It should be kept at a temperature not exceeding 25°C (77°F). Use a tightly sealed container to prevent moisture absorption and ensure the medication remains stable.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Liu Ziying
1400878822@qq.com
Mobile
13986246535
Visit Website
http://www.hubeidahao.comAddress
Hubei Province Tianmen City Huangtan Town Ximiao Village 1 Group